Back to search

Article

CRISPR editing of <i>sftb-1</i> /SF3B1 in <i>C. elegans</i> allows the identification of synthetic interactions with cancer-related mutations and the chemical inhibition of splicing

2019-05-10

Abstract excerpt

<h4>ABSTRACT</h4> SF3B1 is the most frequently mutated splicing factor in cancer. Mutations in SF3B1 confer growth advantages to cancer cells but they may also confer vulnerabilities that can be therapeutically targeted. In contrast to other animal models, SF3B1 cancer mutations can be maintained in homozygosis in C. elegans , allowing synthetic lethal screens with a homogeneous population of animals. These mut...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2f4c4c6e-c988-5a34-8050-cfb83f5be1b7
DOI
10.1101/634634
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR editing of <i>sftb-1</i> /SF3B1 in <i>C. elegans</i> allows the identification of synthetic interactions with cancer-related mutations and the chemical inhibition of splicingDOI 10.1101/634634
Select a neighboring publication to make it the new centre.